In the case analyzed, the study used to measure the percentage of individuals who develop hyperprolactinemia related to use of risperidone – a critical adverse event related to this medication, caused by the increase in prolactin levels and which can cause gynecomastia – was conducted with a population of Thai individuals, which also used a convenience sample (31). This evidence concerns the gene PRL and Gynecomastia.